Insulet | مبيعات



Sales تغيير تاريخ
Abbott USD 10.36B 610M 2025-03
Align Technology USD 979.3M 15.92M 2025-03
AtriCure USD 123.6M 677K 2025-03
Avanos Medical USD 179.6M 9.2M 2024-12
Baxter International USD 2.63B 123M 2025-03
Becton, Dickinson and Co. USD 5.27B 102M 2025-03
Boston Scientific USD 4.66B 99M 2025-03
Cardinal Health USD 54.9B 364M 2025-03
Cooper Companies USD 964.7M 53.7M 2025-01
Dexcom USD 1.04B 73.5M 2025-03
Edwards Lifesciences USD 1.41B 24.2M 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Globus Medical USD 657.29M 31.59M 2024-12
ICU Medical USD 629.8M 40.67M 2024-12
Insulet USD 597.5M 53.6M 2024-12
Integra LifeSciences USD 442.65M 61.81M 2024-12
J&J USD 21.89B 630M 2025-03
Masimo USD 600.7M 96.1M 2024-12
Medtronic USD 8.29B 111M 2025-01
Merit Medical Systems USD 355.4M 242K 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Solventum Corp 2.07B 12M 2024-12
Stryker USD 5.9B 536M 2025-03
Tandem Diabetes Care USD 234.4M 48.25M 2025-03
Teleflex USD 700.67M 94.74M 2025-03
West Pharmaceutical Services USD 698M 50.8M 2025-03
Zimmer Biomet Holdings USD 2.02B 199M 2024-12



Insulet مبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.